We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+1.5%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$21.4B
AUM Growth
-$3.07B
Cap. Flow
-$3.45B
Cap. Flow %
-16.12%
Top 10 Hldgs %
34%
Holding
335
New
40
Increased
37
Reduced
44
Closed
34

Top Buys

Rank Stock Value
1
ARMK icon
Aramark
ARMK
+$209M
2
KSU
Kansas City Southern
KSU
+$193M
3
HWM icon
Howmet Aerospace
HWM
+$184M
4
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$172M
5
TMUS icon
T-Mobile US
TMUS
+$160M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.42B
2
MXIM
Maxim Integrated Products
MXIM
+$476M
3
WTW icon
Willis Towers Watson
WTW
+$468M
4
WORK
Slack Technologies, Inc.
WORK
+$462M
5
AON icon
Aon
AON
+$371M

Sector Composition

Rank Sector Weight
1 Healthcare 28.56%
2 Industrials 11.54%
3 Communication Services 11.47%
4 Financials 11.2%
5 Technology 11.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLACW
251
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$156K ﹤0.01%
187,500
– –
MVLAW
252
DELISTED
Movella Holdings Inc. Warrant
MVLAW
$142K ﹤0.01%
150,000
– –
AUROW
253
Aurora Innovation Warrant
AUROW
$370M
$141K ﹤0.01%
93,750
– –
APGB.WS
254
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$140K ﹤0.01%
150,000
– –
WPCB.WS
255
DELISTED
Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCB.WS
$140K ﹤0.01%
150,000
– –
GTPBW
256
DELISTED
Gores Technology Partners II, Inc. Warrant
GTPBW
$134K ﹤0.01%
120,000
– –
FSRXW
257
DELISTED
FinServ Acquisition Corp. II Warrant
FSRXW
$133K ﹤0.01%
150,000
– –
HERAW
258
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
$129K ﹤0.01%
125,000
– –
STRE.WS
259
DELISTED
Supernova Partners Acquisition Company III, Ltd. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
STRE.WS
$129K ﹤0.01%
140,000
– –
VPCBW
260
DELISTED
VPC Impact Acquisition Holdings II Warrant
VPCBW
$128K ﹤0.01%
106,250
– –
CPARW
261
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
$128K ﹤0.01%
+150,780
New +$180K
TIOAW
262
DELISTED
Tio Tech A Warrants
TIOAW
$126K ﹤0.01%
166,666
– –
LCAHW
263
DELISTED
Landcadia Holdings IV, Inc. Warrant
LCAHW
$125K ﹤0.01%
125,000
– –
TBCPW
264
DELISTED
Thunder Bridge Capital Partners III Inc. Warrant
TBCPW
$113K ﹤0.01%
150,000
– –
GSEVW
265
DELISTED
Gores Holdings VII, Inc. Warrant
GSEVW
$111K ﹤0.01%
93,750
– –
RKTA.WS
266
DELISTED
Rocket Internet Growth Opportunities Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RKTA.WS
$106K ﹤0.01%
125,000
– –
GSQD.WS
267
DELISTED
G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
GSQD.WS
$105K ﹤0.01%
100,000
– –
IPVF.WS
268
DELISTED
InterPrivate III Financial Partners Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
IPVF.WS
$102K ﹤0.01%
79,600
-400
-0.5% -$441
SCOBW
269
DELISTED
ScION Tech Growth II Warrants
SCOBW
$101K ﹤0.01%
150,000
– –
CCVI.WS
270
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$96K ﹤0.01%
80,000
– –
RXRAW
271
DELISTED
RXR Acquisition Corp. Warrants to purchase Class A common stock
RXRAW
$90K ﹤0.01%
120,000
– –
IPVIW
272
DELISTED
InterPrivate IV InfraTech Partners Inc. Warrant
IPVIW
$86K ﹤0.01%
120,000
– –
FRSGW
273
DELISTED
First Reserve Sustainable Growth Corp. Warrant
FRSGW
$83K ﹤0.01%
100,000
– –
CLAA.WS
274
DELISTED
Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CLAA.WS
$81K ﹤0.01%
100,000
– –
GETR.WS
275
DELISTED
Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
GETR.WS
$79K ﹤0.01%
80,000
– –
9 10
11
12 13

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Farallon Capital Management held 335 positions worth $21.4B, down 13% from $24.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Farallon Capital Management withdrew a net $3.45B in Q3 2021, closing 34 positions and reducing 44 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $1.42B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, Farallon Capital Management opened a new position in Macquarie Infrastructure Holdings, LLC worth $177M.

  • Farallon Capital Management's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 4,361,050 shares worth $177M.
  • Farallon Capital Management added most to Aramark in Q3 2021, an estimated $209M increase.
  • Farallon Capital Management's biggest Q3 2021 reduction was Willis Towers Watson, cutting an estimated $468M.
  • Farallon Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.42B.
  • Farallon Capital Management's ten largest holdings make up 34% of its $21.4B portfolio in Q3 2021.
  • Farallon Capital Management opened 40 new positions and closed 34 in Q3 2021.
  • Farallon Capital Management's portfolio value fell 13% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.